These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6998552)

  • 21. Effect of estrogen on the growth hormone response to the alpha-adrenergic agonist clonidine in women with menopausal flushing.
    Tulandi T; Lal S; Guyda H
    J Clin Endocrinol Metab; 1987 Jul; 65(1):6-10. PubMed ID: 2884230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of oestrogen-progestogen with clonidine in the climacteric syndrome.
    Sonnendecker EW; Polakow ES
    S Afr Med J; 1980 Nov; 58(19):753-6. PubMed ID: 6252641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of sialorrhea in Parkinson's disease patients with clonidine. Double-blind, comparative study with placebo].
    Serrano-Dueñas M
    Neurologia; 2003; 18(1):2-6. PubMed ID: 12590375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonidine and analgesic duration after popliteal fossa nerve blockade: randomized, double-blind, placebo-controlled study.
    YaDeau JT; LaSala VR; Paroli L; Kahn RL; Jules-Elysée KM; Levine DS; Wukovits BL; Lipnitsky JY
    Anesth Analg; 2008 Jun; 106(6):1916-20. PubMed ID: 18499632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms.
    Dishy V; Liu F; Ebel DL; Atiee GJ; Royalty J; Reilley S; Paolini JF; Wagner JA; Lai E
    J Clin Pharmacol; 2009 Apr; 49(4):416-22. PubMed ID: 19246721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonidine in the treatment of essential tremor.
    Koller W; Herbster G; Cone S
    Mov Disord; 1986; 1(4):235-7. PubMed ID: 3332805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D; Posea C; Ceausu I; Rusu M
    Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A new antihypertensive agent used in a clinical setting].
    Wetzels E; Raschig A; Kaiser HJ
    Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study.
    Honkaniemi J; Liimatainen S; Rainesalo S; Sulavuori S
    Headache; 2006 May; 46(5):781-7. PubMed ID: 16643581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dosage clonidine (Dixarit) in menopausal flushing.
    Evans J; Hailes J
    Med J Aust; 1979 Jul; 2(1):45-6. PubMed ID: 502951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
    Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G
    Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study.
    Carr DB; Goudas LC; Denman WT; Brookoff D; Staats PS; Brennen L; Green G; Albin R; Hamilton D; Rogers MC; Firestone L; Lavin PT; Mermelstein F
    Pain; 2004 Mar; 108(1-2):17-27. PubMed ID: 15109503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Malonne H; Coffiner M; Sonet B; Sereno A; Vanderbist F
    Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical use of a preparation based on phyto-oestrogens in the treatment of menopausal disorders.
    Russo R; Corosu R
    Acta Biomed; 2003 Dec; 74(3):137-43. PubMed ID: 15055018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders.
    Du YS; Li HF; Vance A; Zhong YQ; Jiao FY; Wang HM; Wang MJ; Su LY; Yu DL; Ma SW; Wu JB
    Aust N Z J Psychiatry; 2008 Sep; 42(9):807-13. PubMed ID: 18696285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.